AzTrials
AzTrials

Well-Being, PsychologicalNCT06824480

The Effect of Postpartum Debriefing on the Psychological Outcomes

A study testing debriefing group in people with Well-Being, Psychological, run by Mersin University at 2 sites in Turkey (Türkiye).

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study was planned to determine the effect of re-signification of birth in the early postpartum period on postpartum fear of childbirth, postpartum depression and birth trauma. Read more about this study

Who is it for?
Ages 18 to 45 years, women onlyHealthy volunteers can take part
Conditions the study is for
Well-Being, Psychological
What is being tested?
debriefing group
Could I receive a placebo?
No, everyone receives an active treatment
How many people
72 participants
Where
2 sitesTurkey (Türkiye)
Study dates
1 Feb 2024to 15 Jun 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Women who volunteer to participate in the study, Whose mother tongue is Turkish, Who are between the ages of 18-45, Who are at least primary school graduates, Who are 37-42 weeks pregnant, Who are nulliparous, Who have a healthy pregnancy, Who do not have a psychological condition or psychiatric disorder, Who are monitored and cared for in the first 24 hours after birth at the Tarsus State Hospital Maternity Department, Who approve of the reinterpretation of birth application to be carried out by the researcher will be included in the sample.

Who cannot join

  • Those who did not volunteer to participate in the study, Those who gave birth before the 37th week of pregnancy, Those who were multiparous, Those who had abnormal medical conditions during pregnancy (placental disorder, preeclampsia, premature birth threat, etc.),
  • Those whose native language is not Turkish, Those who have visual, speech and hearing impairments, Those who had an emergency cesarean section, Those who stayed in the hospital for less than 12 hours after birth, Those who received a psychiatric diagnosis during the postpartum period (except those diagnosed with postpartum depression and post-traumatic stress disorder related to birth), Those who could not be reached by phone during the follow-up of the study, Women who developed complications in the first 24 hours after birth and required intensive care, Those whose babies required neonatal intensive care during the postpartum period, Those who experienced another life event that traumatized the woman during the postpartum period (harassment, rape, earthquake, accident, loss of a loved one) etc.) Those who want to withdraw from the study at any stage of the study will not be included in the sample.

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

gozde gokce ısbir professor dr. Gozde GOKCE ISBIR contact

+905057782319

gozdegokce@gmail.com

Turkey (Türkiye)2 sites, 2 recruiting
  • Mersin university

    Mersin

    Recruiting
  • Mersin University

    Mersin

    Mersin University Mersin University, +903243610001

    Recruiting

Other trials in Turkey (Türkiye)

About this study

Official title: The Effect of Debriefing of Childbirth in the Early Postpartum Period on the Psychological Outcomes

This study was planned to determine the effect of re-signification of birth in the early postpartum period on postpartum fear of childbirth, postpartum depression and birth trauma.

Read the detailed description

This study was contucted between february 2024 and June 2025 in Turkey , as a single-blind randomized controlled experimental study to determine the effect of reinterpretation of birth on postpartum fear of childbirth, postpartum depression and birth trauma.During data collection, participants were informed about the purpose of the study and those who volunteered to participate in the research were accepted into the study by signing an informed consent form.Data; When the study was approved, it was planned to be collected face to face within the first 12-24 hours after birth and by telephone within 6-8 weeks after birth. CONSORT directive was followed in the research planning.

Being tested
debriefing group, control group
Keywords
debriefing, trauma, fear, depression
Medical subject headings
Psychological Well-Being, Wounds and Injuries, Depression

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • debriefing groupBehavioural

    Women who volunteered to participate in the study and met the participation criteria were informed about the study. The first session will be held face to face in the clinic for 40 minutes. Then, the second session will be held by phone within 4-6 weeks after birth, with a total of 2 meetings with each woman for approximately 40 minutes.

  • control groupBehavioural

    he women in the control group will be asked how the birth went within 12-24 hours after birth by the researcher as part of their routine care, but no detailed analysis or interpretation will be made.

Study groups in NCT06824480
Study groupRoleWhat they receive
experimental: debriefing grupExperimentalWomen who volunteered to participate in the study and met the participation criteria were informed about the study. The first session will be held face to face in the clinic for 40 minutes. Then, the second session will be held by phone within 4-6 weeks after birth, with a total of 2 meetings with each woman for approximately 40 minutes.
Receives: Behavioral: debriefing group
experimental: control grupExperimentalThe women in the control group will be asked how the birth went within 12-24 hours after birth by the researcher as part of their routine care, but no detailed analysis or interpretation will be made.
Receives: Behavioral: control group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Personal Information Form

    It includes women's sociodemographic characteristics, education and employment status, and contact information.

    Measured: the first 12-24 hours after birth

  2. Birth Process Evaluation Form

    It consists of 22 questions that include obstetric characteristics related to labor (gestational week, pregnancy planning/desire) and interventions performed during birth.

    Measured: the first 12-24 hours after birth

  3. Wijma Birth Expectation/Experience Scale B version (W-DBÖ-B) at Birth:

    Wijma Birth Expectation/Experience Scale (W-DEQ) was developed by Klaas and Barbro Wijma (1998) to measure the fear of birth experienced by women. The scale consists of 32 items. The answers on the scale are numbered from 0 to 5 and are in the six-point Likert type. 0 is expressed as "completely" and 5 is expressed as "not at all". The minimum score on the scale is 0, while the maximum score is 160. As the score increases, the fear of childbirth experienced by women increases. Questions numbered 2, 3, 6, 7, 10, 11, 14, 18, 19, 23, 24, 26, 30 are calculated by reversing the scale. The scale, which was adapted to Turkish by Körükcü, Bulut and Kukulu and its validity and reliability were made, has six sub-dimensions. These dimensions are determined as Anxiety about contractions (items 1,2,6,11,15,16,18,23), inadequacy in positive behaviors (items 24,25,26,30), loneliness (items 3,7,10,14,19,21,22

    Measured: the first 12-24 hours after birth

  4. Wijma Birth Expectation/Experience Scale B version (W-DBÖ-B) at Birth: (ANNEX-3)

    Wijma Birth Expectation/Experience Scale (W-DEQ) was developed by Klaas and Barbro Wijma (1998) to measure the fear of birth experienced by women. The scale consists of 32 items. The answers on the scale are numbered from 0 to 5 and are in the six-point Likert type. 0 is expressed as "completely" and 5 is expressed as "not at all". The minimum score on the scale is 0, while the maximum score is 160. As the score increases, the fear of childbirth experienced by women increases. Questions numbered 2, 3, 6, 7, 10, 11, 14, 18, 19, 23, 24, 26, 30 are calculated by reversing the scale. The scale, which was adapted to Turkish by Körükcü, Bulut and Kukulu and its validity and reliability were made, has six sub-dimensions. These dimensions are determined as Anxiety about contractions (items 1,2,6,11,15,16,18,23), inadequacy in positive behaviors (items 24,25,26,30), loneliness (items 3,7,10,14,19,21,22

    Measured: first 6-8 weeks after birth

  5. City Birth Trauma Scale (CityBiTS)

    The City Birth Trauma Scale (CityBiTS) was developed by Susan Ayers and colleagues to assess PTSD and its symptoms in the postpartum period. The original measurement tool had a Cronbach's Alpha coefficient of 0.92 for the entire scale and between 0.82 and 0.88 for the subscales The scale consists of 29 items and is a four-point Likert-type scale. The scale assesses symptoms of stress (items 1-2), re-experiencing (items 3-7), avoidance (items 8-9), negative cognitions and mood (items 10-16), and hyperarousal (items 17-22). In addition, items 23 and 24 of the scale focus on dissociative symptoms, with a score of "0" in item 25 indicating pre-partum onset of PTSD and a score of "2" indicating delayed onset PTSD. The duration of symptoms is assessed with item 26. While distress and impairment symptoms are assessed with items 27 and 28, the last item of the scale (item 29) is the exclusion criterion for PTSD . Items 3-22 can be scored on the scale and a score between 0-60 can be.

    Measured: first 6-8 weeks after birth

  6. Edinburgh Postpartum Depression Scale (EDPS)

    EPDS was developed by Cox and colleagues in 1987 and is a measurement tool that determines the risk, level, and severity of depression in the postpartum period. The scale is a self-assessment scale. The measurement tool consists of 10 items on a four-point Likert-type scale evaluated between 0 and 3. The highest score that can be obtained from the scale is 30. Questions 1, 2, and 4 on the scale are scored in the format 0-1-2-3, while questions 3, 5, 6, 7, 8, 9, and 10 are scored in the format 3-2-1-0. The cut-off point of the scale was calculated as 13. Cronbach's alpha value of the original version of EPDS was determined as 0.87. The Turkish validity and reliability study of the scale was conducted by Aydın and his colleagues in 2004, and Cronbach's alpha value was determined as 0.72.

    Measured: first 6-8 weeks after birth

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Feb 2025
  2. Study start1 Feb 2024
  3. Primary completion7 Feb 2025
  4. Study completion15 Jun 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
72 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06824480
Sponsor's protocol ID
VBalci
Status last verified
Feb 2025
First submitted
7 Feb 2025
Last updated
8 May 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing debriefing group in people with Well-Being, Psychological, run by Mersin University at 2 sites in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 8 May 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact gozde gokce ısbir professor dr. Gozde GOKCE ISBIR (+905057782319, gozdegokce@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Personal Information Form (time frame: the first 12-24 hours after birth). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 May 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in